Author

P. Panwar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Gutnov· 1 shared A. O'Neill· 1 shared A. Pustilnik· 1 shared B. A. Heinz· 1 shared C. A. Cohen· 1 shared C. Pritchard· 1 shared C. V. Badger· 1 shared D. Foster· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Gutnov

Author profile →

2 papers

Recent·Most cited

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

K. Westendorf, S. Zentelis, L. Wang, D. Foster, P. Vaillancourt, M. Wiggin, E. Lovett, R. van der Lee, J. Hendle, A. Pustilnik, J. M. Sauder, L. Kraft, Y. Hwang, R. W. Siegel, J. Chen, , Ramamurt

This paper identifies LY-CoV1404, a potent SARS-CoV-2 neutralizing antibody effective against multiple variants, including Omicron and Delta, due to its conserved epitope and resistance to common mutations.

bioRxiv · Apr 30, 2021Immunology

Lead optimisation of dehydroemetine for repositioned use in malaria

P. Panwar, K. Burusco, M. Abubaker, H. Matthews, A. Gutnov, E. Fernandez-Alvaro, R. Bryce, J. Wilkinson, N. J. Nirmalan

This paper optimizes 2,3-dehydroemetine for repositioned use in malaria by showing its potency against P. falciparum and lack of cardiotoxicity.

bioRxiv · Feb 1, 2019Microbiology